RS51154B - Farmaceutske kompozicije koje sadrže niske koncentracije peroksida za lečenje i sprečavanje vaginalnih infekcija - Google Patents

Farmaceutske kompozicije koje sadrže niske koncentracije peroksida za lečenje i sprečavanje vaginalnih infekcija

Info

Publication number
RS51154B
RS51154B YUP-366/04A YUP36604A RS51154B RS 51154 B RS51154 B RS 51154B YU P36604 A YUP36604 A YU P36604A RS 51154 B RS51154 B RS 51154B
Authority
RS
Serbia
Prior art keywords
peroxide
vagina
composition
vaginal
amount
Prior art date
Application number
YUP-366/04A
Other languages
English (en)
Serbian (sr)
Inventor
Howard L. Levine
William J. Bologna
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of RS36604A publication Critical patent/RS36604A/sr
Publication of RS51154B publication Critical patent/RS51154B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YUP-366/04A 2001-10-29 2002-10-28 Farmaceutske kompozicije koje sadrže niske koncentracije peroksida za lečenje i sprečavanje vaginalnih infekcija RS51154B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33068301P 2001-10-29 2001-10-29
US10/278,910 US7709026B2 (en) 2001-10-29 2002-10-24 Low concentration of peroxide for treating or preventing vaginal infections
PCT/EP2002/012043 WO2003037382A1 (en) 2001-10-29 2002-10-28 Low concentration of peroxide for treating or preventing vaginal infections

Publications (2)

Publication Number Publication Date
RS36604A RS36604A (sr) 2006-12-15
RS51154B true RS51154B (sr) 2010-10-31

Family

ID=26959335

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-366/04A RS51154B (sr) 2001-10-29 2002-10-28 Farmaceutske kompozicije koje sadrže niske koncentracije peroksida za lečenje i sprečavanje vaginalnih infekcija

Country Status (30)

Country Link
US (1) US7709026B2 (https=)
EP (1) EP1441769B1 (https=)
JP (2) JP5153049B2 (https=)
KR (1) KR101009146B1 (https=)
CN (1) CN1578676A (https=)
AR (1) AR037047A1 (https=)
AT (1) ATE297222T1 (https=)
AU (1) AU2002346897B2 (https=)
BR (1) BR0213584A (https=)
CA (1) CA2465133C (https=)
DE (1) DE60204584T2 (https=)
DK (1) DK1441769T3 (https=)
ES (1) ES2243772T3 (https=)
HR (1) HRP20040480B1 (https=)
HU (1) HU229487B1 (https=)
IL (2) IL161512A0 (https=)
MA (1) MA26289A1 (https=)
ME (1) MEP34608A (https=)
MX (1) MXPA04003977A (https=)
MY (1) MY137791A (https=)
NO (1) NO20042199L (https=)
NZ (1) NZ532294A (https=)
PE (1) PE20030492A1 (https=)
PL (2) PL402550A1 (https=)
PT (1) PT1441769E (https=)
RS (1) RS51154B (https=)
RU (1) RU2329829C2 (https=)
SI (1) SI1441769T1 (https=)
WO (1) WO2003037382A1 (https=)
ZA (1) ZA200402943B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
DE10328942A1 (de) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US20050276865A1 (en) * 2004-05-20 2005-12-15 Servet Buyuktimkin Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
US20120074014A1 (en) * 2010-09-27 2012-03-29 Lutran Industries, Inc. Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
US9895311B2 (en) 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
CN110913849A (zh) * 2017-03-30 2020-03-24 科学派有限责任公司 治疗和预防感染的方法
CA3063208A1 (en) 2017-05-23 2018-11-29 Pharmiva Ab Foam-forming compositions for delivering an active to a body cavity
BR112021007877A2 (pt) * 2018-10-26 2021-08-03 Viramal Limited composição em gel mucoadesiva
US11850303B2 (en) 2020-10-27 2023-12-26 Uqora, Inc. Gel and a suppository and methods to provide the gel and suppository
EP4709404A1 (en) * 2023-05-09 2026-03-18 BioNTech SE Intravaginal formulations of gardnerella endolysins
AR134648A1 (es) * 2023-12-12 2026-02-04 BioNTech SE Composiciones que comprenden una endolisina y sus usos
WO2025217642A1 (en) * 2024-04-12 2025-10-16 The General Hospital Corporation System and method of treating vaginal infections and inflammation

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
NL88710C (https=) * 1954-01-25
NL230864A (https=) * 1957-08-27
US4127515A (en) * 1974-10-21 1978-11-28 Colgate-Palmolive Company Waxing sponge
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
GB8505402D0 (en) * 1985-03-02 1985-04-03 Ciba Geigy Ag Modified phenolic resins
US4657935A (en) * 1985-07-22 1987-04-14 Carlos Teplicki Real acne control (RAC)
US4923677A (en) * 1985-08-07 1990-05-08 Roy T. Witkin Chemical sterilization
US4997625A (en) * 1985-08-07 1991-03-05 Simon Gilbert I Chemical sterilization
US4670256A (en) * 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
US4781923A (en) * 1987-07-20 1988-11-01 Pellico Michael A Antiseptic gels
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5376006A (en) * 1990-03-22 1994-12-27 Ultradent Products, Inc. Dental bleaching compositions and methods for bleaching teeth surfaces
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5573765A (en) * 1991-02-19 1996-11-12 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
US5340836A (en) * 1991-02-19 1994-08-23 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
IL97930A (en) * 1991-04-23 1996-06-18 Perio Prod Ltd Preparations for whitening two controlled release products that contain a super-oxygen compound
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
US5667817A (en) * 1992-03-20 1997-09-16 Alcide Corporation Method and composition for prevention and treatment of female lower genital tract microbial infections
US5898037A (en) * 1992-11-13 1999-04-27 Marx; Alvin J. Formulations of magnesium compounds for local application and methods of treatment using the same
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US6200557B1 (en) * 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition
US5489435A (en) * 1993-07-06 1996-02-06 Ratcliff; Perry A. Composition for treatment of abnormal conditions of the epithelium of bodily orifices
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
UA39965C2 (uk) * 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5741525A (en) * 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
HU228350B1 (hu) * 1995-12-27 2013-03-28 Tibotec Pharm Ltd Bioadhezív, szilárd gyógyszeradagolási forma
US5778886A (en) * 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US5819742A (en) * 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US5843998A (en) * 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US6117859A (en) * 1997-11-04 2000-09-12 The Research Foundation Of State University Of New York Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides
WO1999065538A1 (en) 1998-06-19 1999-12-23 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
US6277363B1 (en) * 1998-09-21 2001-08-21 Vortech, Inc. Method and composition for treating chlamydia infection
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
CA2386422A1 (en) 1999-10-22 2001-04-26 Lif-Hlaup Ehf. Bio-Gels Pharmaceuticals Inc. Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
US6200551B1 (en) * 2000-01-27 2001-03-13 Susan Ann Morgan Treatment for dry mouth employing carbamide peroxide
US6235314B1 (en) * 2000-08-08 2001-05-22 Sarfaraz K. Niazi Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
JP4086658B2 (ja) * 2000-10-02 2008-05-14 ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク 抗菌薬および抗炎症剤としてのナフチルサリチルアニリド
US20030211173A1 (en) 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
WO2005014064A1 (en) * 2003-08-06 2005-02-17 Basf Aktiengesselschaft Water-swellable material comprising coated water-swellable polymers
US20090156672A1 (en) * 2007-12-17 2009-06-18 Northwestern University Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities

Also Published As

Publication number Publication date
RU2004116312A (ru) 2005-04-10
BR0213584A (pt) 2004-08-24
US7709026B2 (en) 2010-05-04
HRP20040480B1 (hr) 2007-11-30
ZA200402943B (en) 2005-03-30
IL161512A0 (en) 2004-09-27
NO20042199L (no) 2004-05-26
IL161512A (en) 2009-07-20
MEP34608A (en) 2011-02-10
RU2329829C2 (ru) 2008-07-27
DK1441769T3 (da) 2005-09-12
AR037047A1 (es) 2004-10-20
DE60204584T2 (de) 2006-03-16
CN1578676A (zh) 2005-02-09
HUP0401672A3 (en) 2008-04-28
JP5153049B2 (ja) 2013-02-27
MXPA04003977A (es) 2004-07-08
PL402550A1 (pl) 2013-08-05
AU2002346897B2 (en) 2008-04-17
HUP0401672A2 (hu) 2005-07-28
PE20030492A1 (es) 2003-06-16
ATE297222T1 (de) 2005-06-15
EP1441769B1 (en) 2005-06-08
PL369725A1 (en) 2005-05-02
DE60204584D1 (de) 2005-07-14
KR20050056903A (ko) 2005-06-16
PL216746B1 (pl) 2014-05-30
KR101009146B1 (ko) 2011-01-18
ES2243772T3 (es) 2005-12-01
MY137791A (en) 2009-03-31
HU229487B1 (en) 2014-01-28
HK1063290A1 (en) 2004-12-24
JP2005510505A (ja) 2005-04-21
HRP20040480A2 (en) 2004-10-31
MA26289A1 (fr) 2004-09-01
US20030091644A1 (en) 2003-05-15
JP2010248232A (ja) 2010-11-04
NZ532294A (en) 2006-12-22
RS36604A (sr) 2006-12-15
CA2465133A1 (en) 2003-05-08
WO2003037382A1 (en) 2003-05-08
PT1441769E (pt) 2005-08-31
CA2465133C (en) 2012-03-06
EP1441769A1 (en) 2004-08-04
SI1441769T1 (sl) 2005-12-31

Similar Documents

Publication Publication Date Title
JP2010248232A (ja) 膣感染を処置又は予防するための低濃度のペルオキサイド
US6017521A (en) Use of polycarboxylic acid polymers to treat vaginal infections
US5741525A (en) Vaginal pharmaceutical hydrogen peroxide composition
CN102470117B (zh) 一种以苯甲酸和有机酸防腐剂相联合作为有效成分的组合物及其用途
AU2002346897A1 (en) Low concentration of peroxide for treating or preventing vaginal infections
EP1784176B1 (en) Composition comprising lactic acid and lactoferrin
US6479045B2 (en) Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
Tammela et al. Intravesical prostaglandin F2 for promoting bladder emptying after surgery for female stress incontinence
EP3501507A1 (en) Macrogols for application to the mucosa, and therapeutic uses thereof
HK1063290B (en) Pharmaceutical formulations containing low concentrations of peroxide for treating or preventing vaginal infections
TWI337084B (en) Pharmaceutical composition containing low concentration of peroxide for treating or preventing vaginal infections
JP2007077150A (ja) 酸−酸緩衝系を含有する無水組成物
EP0477143B1 (en) Pharmaceutical composition having a cicatrising effect
US20040131686A1 (en) Composition and method for treatment of bacterial vaginal infections
JPH01283217A (ja) 皮膚疾患治療剤